During the past decade, Buenos Aires Skin conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Buenos Aires Skin" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Buenos Aires Skin" are "Atopic Dermatitis" (3 trials), "Alopecia Areata" (1 trials), "Psoriasis" (1 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Buenos Aires Skin" in a lesser frequency.

Most popular intervention types in "Buenos Aires Skin" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Baricitinib" (3 trials), "Enpatoran high dose" (1 trials), "Enpatoran low dose" (1 trials) and "Enpatoran medium dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Buenos Aires Skin" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Buenos Aires Skin". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Buenos Aires Skin, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Buenos Aires Skin, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".